Matches in Wikidata for { <http://www.wikidata.org/entity/Q94151123> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q94151123 description "article scientifique publié en 2018" @default.
- Q94151123 description "wetenschappelijk artikel" @default.
- Q94151123 description "наукова стаття" @default.
- Q94151123 name "PDCT-02. COMBINED INHIBITION OF MTORC1/C2 AND MEK PATHWAY IS SYNERGISTIC IN PRECLINICAL TESTING OF PEDIATRIC LOW-GRADE GLIOMA INCLUDING A NOVEL PATIENT-DERIVED NF1 PILOCYTIC ASTROCYTOMA CELL LINE" @default.
- Q94151123 name "PDCT-02. COMBINED INHIBITION OF MTORC1/C2 AND MEK PATHWAY IS SYNERGISTIC IN PRECLINICAL TESTING OF PEDIATRIC LOW-GRADE GLIOMA INCLUDING A NOVEL PATIENT-DERIVED NF1 PILOCYTIC ASTROCYTOMA CELL LINE" @default.
- Q94151123 type Item @default.
- Q94151123 label "PDCT-02. COMBINED INHIBITION OF MTORC1/C2 AND MEK PATHWAY IS SYNERGISTIC IN PRECLINICAL TESTING OF PEDIATRIC LOW-GRADE GLIOMA INCLUDING A NOVEL PATIENT-DERIVED NF1 PILOCYTIC ASTROCYTOMA CELL LINE" @default.
- Q94151123 label "PDCT-02. COMBINED INHIBITION OF MTORC1/C2 AND MEK PATHWAY IS SYNERGISTIC IN PRECLINICAL TESTING OF PEDIATRIC LOW-GRADE GLIOMA INCLUDING A NOVEL PATIENT-DERIVED NF1 PILOCYTIC ASTROCYTOMA CELL LINE" @default.
- Q94151123 prefLabel "PDCT-02. COMBINED INHIBITION OF MTORC1/C2 AND MEK PATHWAY IS SYNERGISTIC IN PRECLINICAL TESTING OF PEDIATRIC LOW-GRADE GLIOMA INCLUDING A NOVEL PATIENT-DERIVED NF1 PILOCYTIC ASTROCYTOMA CELL LINE" @default.
- Q94151123 prefLabel "PDCT-02. COMBINED INHIBITION OF MTORC1/C2 AND MEK PATHWAY IS SYNERGISTIC IN PRECLINICAL TESTING OF PEDIATRIC LOW-GRADE GLIOMA INCLUDING A NOVEL PATIENT-DERIVED NF1 PILOCYTIC ASTROCYTOMA CELL LINE" @default.
- Q94151123 P1433 Q94151123-E7E02548-6249-4EE4-A2B2-AF183A6CC64E @default.
- Q94151123 P1476 Q94151123-747826D8-00BB-4EE8-ABF4-09787687FA17 @default.
- Q94151123 P2093 Q94151123-2B9BC73A-C4FF-4E52-A07D-9B009F630DEB @default.
- Q94151123 P2093 Q94151123-7799D63B-B885-41E7-9C62-9333B73C6E7F @default.
- Q94151123 P2093 Q94151123-7A18706E-FD60-4073-B9FB-6A57DC0847DE @default.
- Q94151123 P2093 Q94151123-DF031266-D676-4147-985F-64BB86665740 @default.
- Q94151123 P2093 Q94151123-FD0FC561-919A-40B6-8E97-263F8EC74DEA @default.
- Q94151123 P304 Q94151123-26A819ED-D737-4880-BAC3-BB56B7E1EF59 @default.
- Q94151123 P31 Q94151123-2D71625C-38C9-4B92-8DDD-5ED665335683 @default.
- Q94151123 P356 Q94151123-072864AB-5C69-4A36-A512-5CB38FC57E52 @default.
- Q94151123 P433 Q94151123-75B73EE1-A42F-4ADF-B2E6-627D6190CE5C @default.
- Q94151123 P478 Q94151123-D641E779-6053-49E3-B50A-64835A48BA9B @default.
- Q94151123 P577 Q94151123-22E56DC3-BDAD-40AC-A1A4-4F4589002396 @default.
- Q94151123 P921 Q94151123-5978BE01-39A1-4B80-9A75-1321702D4EE3 @default.
- Q94151123 P921 Q94151123-968CE081-8214-47B6-8FE3-142556AEFB26 @default.
- Q94151123 P921 Q94151123-FC7BCDA1-884A-4185-9228-A677A92505C1 @default.
- Q94151123 P932 Q94151123-EBE76C3F-3439-46BB-A60C-916B735C1581 @default.
- Q94151123 P356 NOY148.832 @default.
- Q94151123 P1433 Q15724471 @default.
- Q94151123 P1476 "PDCT-02. COMBINED INHIBITION OF MTORC1/C2 AND MEK PATHWAY IS SYNERGISTIC IN PRECLINICAL TESTING OF PEDIATRIC LOW-GRADE GLIOMA INCLUDING A NOVEL PATIENT-DERIVED NF1 PILOCYTIC ASTROCYTOMA CELL LINE" @default.
- Q94151123 P2093 "Antje Arnold" @default.
- Q94151123 P2093 "Charles Eberhart" @default.
- Q94151123 P2093 "Eric Raabe" @default.
- Q94151123 P2093 "Fausto Rodriguez" @default.
- Q94151123 P2093 "Ming Yuan" @default.
- Q94151123 P304 "vi200-vi201" @default.
- Q94151123 P31 Q13442814 @default.
- Q94151123 P356 "10.1093/NEUONC/NOY148.832" @default.
- Q94151123 P433 "Suppl 6" @default.
- Q94151123 P478 "20" @default.
- Q94151123 P577 "2018-11-05T00:00:00Z" @default.
- Q94151123 P921 Q102294353 @default.
- Q94151123 P921 Q177755 @default.
- Q94151123 P921 Q2095252 @default.
- Q94151123 P932 "6216989" @default.